AI assistant
Sending…
ImmunityBio, Inc. — Director's Dealing 2025
Dec 16, 2025
31529_dirs_2025-12-16_216d906c-71b8-4dab-b88e-dc93ea0db478.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: ImmunityBio, Inc. (IBRX)
CIK: 0001326110
Period of Report: 2025-12-12
Reporting Person: Wendel Bruce (Director)
More from ImmunityBio, Inc.
Regulatory Filings
2026
May 18
Interim / Quarterly Report
2026
May 7
Regulatory Filings
2026
May 7
Regulatory Filings
2026
Apr 9
Regulatory Filings
2026
Apr 6
Regulatory Filings
2026
Mar 31
Director's Dealing
2026
Feb 26
Director's Dealing
2026
Feb 24
Director's Dealing
2026
Feb 24
Director's Dealing
2026
Feb 24